Publication | Closed Access

Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma

UrologyOverall SurvivalGenitourinary CancerImvigor010 TrialMedicineTumor Dna StatusCancer TreatmentOncologyRadiation Oncology